22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market
20 juin 2023 07h00 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., June 20, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis...
22nd Century Group VP of Regulatory Science to Participate in FDLI Panel in Response to Recent FDA Action on Comprehensive Plan and Reduced Nicotine Mandate
13 oct. 2021 16h01 HE
|
22nd Century Group, Inc
Company Supports This Week’s Positive FDA Action on E-Cigarettes, Demonstrating the Agency’s Commitment to Providing Adult Smokers with Alternatives to Highly Addictive CigarettesApplauds FDA’s Active...
22nd Century Group to Ring Nasdaq Closing Bell Today, August 16
16 août 2021 09h20 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., Aug. 16, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII) (formerly NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm...
22nd Century Advances Initiatives to Strengthen and Maximize Revenue Opportunities in Hemp/Cannabis Franchise
07 juin 2021 10h42 HE
|
22nd Century Group, Inc
Close Partnership With Aurora Cannabis Inc. to Enforce Shared Global Biosynthesis IP Rights Against Infringement and Actively Explore Commercial Development Opportunities; Monetization of Key Patented...
22nd Century Announces $40 Million Common Stock Registered Direct Offering
07 juin 2021 09h25 HE
|
22nd Century Group, Inc
BUFFALO, N.Y., June 07, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Intrusion, LifeMD, Romeo Power, and Acadia Pharmaceuticals and Encourages Investors to Contact the Firm
28 avr. 2021 20h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 28, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf...
Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry
19 mars 2021 13h00 HE
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 19, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
12 mars 2021 10h00 HE
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 12, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
11 mars 2021 07h00 HE
|
22nd Century Group, Inc
Key Business and Financial Highlights 22nd Century has a tremendous global commercial opportunity in the more than $800 billion markets across the tobacco and hemp/cannabis industry.Securing Modified...
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
04 mars 2021 09h15 HE
|
22nd Century Group, Inc
WILLIAMSVILLE, N.Y., March 04, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company focused on tobacco harm reduction, very low...